Billionaire and celebrity entrepreneur Mark Cuban has revealed his latest move to tackle the cost of medicines in the US, agreeing a deal to make a low-cost biosimilar version of AbbVie’s blockbuster ...
After trailing broader equities over the past few years, will the healthcare sector finally bounce back in 2026? It's hard to ...
While there are already a number of biosimilars of AbbVie's big-selling Humira on the US market, so far, only one – Boehringer Ingelheim's Cyltezo – is interchangeable with the original, a coveted ...
With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about ...
News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. Baillie Gifford’s three stocks driving positiv ...
Quantum education in the UK is fragmented and poorly advertised. Raising awareness of available training and career pathways will expand and strengthen the quantum workforce and is essential to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback